Chris Cleary - 03 Feb 2025 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Director
Signature
/s/ Andrew Taylor, Attorney-in-Fact
Issuer symbol
OBIO
Transactions as of
03 Feb 2025
Net transactions value
$0
Form type
4
Filing time
05 Feb 2025, 16:16:30 UTC
Previous filing
05 Feb 2025
Next filing
26 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OBIO Common Stock, par value $0.0001 per share ("Common Stock") Award $0 +10,155 $0.000000 10,155 03 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OBIO Stock Option (Right to Buy) Award $0 +30,742 $0.000000 30,742 03 Feb 2025 Common Stock 30,742 $5.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on February 3, 2025. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest as follows: (1) 2,987 RSUs vest on June 24, 2025 and (2) the remaining 7,168 RSUs vest in three equal, annual installments beginning on February 3, 2026, subject to the Reporting Person's continuous service through such dates.
F2 The stock options shall vest as follows: (1) 9,223 stock options shall vest on June 24, 2025 and (2) the remaining 21,519 stock options shall vest in three equal, annual installments beginning on February 3, 2026, subject to the Reporting Person's continuous service through such date.